Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS) as a Neuroimaging Biomarker of Glymphatic Function in Neurodegenerative Diseases: A Systematic Review.

Overview

1. Faculty of Medicine, University of Brasília (UnB), Brasília 70910-900, Brazil; (R.L.O.); (O.T.N.); (D.D.d.C.B.); (F.v.G.)
2. Department of Clinical Medicine, Geriatric Medicine Centre, University Hospital of Brasília, University of Brasília (UnB), Brasília 70910-900, Brazil
3. Department of Physical Education, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil; (N.R.A.); (D.A.S.S.); (C.J.B.)
4. Escuela de Kinesiologia, Universidad Santo Tomás, Puerto Montt 5480000, Chile
5. Diagnostic Imaging Unit, University Hospital of Brasília, Brasília 70840-901, Brazil
6. Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, QC H4B 1R6, Canada; (A.P.); (T.T.D.-V.)
7. Centre de Recherche de l’Institut Universitaire de Gériatrie de Montréal (CRIUGM), Montreal, QC H3W 1W5, Canada

Abstract

The glymphatic system has been proposed as a brain-wide pathway that promotes the exchange between cerebrospinal and interstitial fluids and facilitates the clearance of metabolic waste products, including amyloid-β and tau proteins. Diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) has emerged as a non-invasive magnetic resonance imaging technique proposed to indirectly assess glymphatic-related fluid dynamics. This systematic review evaluated the methodological consistency and clinical applicability of the ALPS index in neurodegenerative diseases. A structured search of PubMed (MEDLINE) and Web of Science identified human studies published up to January 2026 investigating DTI-ALPS in neurodegenerative conditions. Data regarding study populations, MRI acquisition parameters, image-processing methods, statistical approaches, and clinical associations were extracted and synthesized. Ten studies met the inclusion criteria. Across studies, lower ALPS index values were generally associated with cognitive impairment, amyloid burden, and disease severity, particularly in Alzheimer’s disease. Several studies incorporated multimodal biomarkers, including amyloid positron emission tomography and cerebrospinal fluid markers, thereby improving the biological interpretation of DTI-ALPS findings. However, substantial methodological heterogeneity was identified across studies, including variability in region-of-interest placement, diffusion acquisition protocols, and image-processing pipelines. Furthermore, the interpretation of diffusivity metrics as direct measures of glymphatic flow remains controversial. Current evidence suggests that DTI-ALPS may represent a promising non-invasive imaging marker of glymphatic-related alterations; however, its biological specificity and clinical applicability remain insufficiently established. Standardized acquisition protocols, harmonized analytical pipelines, and longitudinal multicenter studies are required to clarify its role in neurodegenerative disease research.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• osf:4rytn — at OSF; found in “Data Availability Statement”

Data Availability Statement

The data supporting the findings of this study are publicly available in the Open Science Framework (OSF) repository at: https://osf.io/4rytn (DOI: https://doi.org/10.17605/OSF.IO/4RYTN) (accessed on 8 June 2026). The repository contains the full extracted dataset, a structured study-characteristics table (Appendix A), and supporting materials used for data synthesis and visualization.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 5 keywords, 9 MeSH terms, 2 funders, 22 references.

Cite

This paper

Olegário, R. L., Nóbrega, O. T., Almeida, N. R., Soto, D. A. S., Brito, C. J., Bispo, D. D. d. C., von Glehn, F., Páez, A., Dang-Vu, T. T., & Camargos, E. F. (2026). Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS) as a Neuroimaging Biomarker of Glymphatic Function in Neurodegenerative Diseases: A Systematic Review. International journal of molecular sciences, 27(13), 5758. https://doi.org/10.3390/ijms27135758

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1002/trc2.70304 [code]

Thalamic volume alterations mediate glymphatic function and cognitive dysfunction in Alzheimer's disease.

Journal: Alzheimer's & dementia (New York, N. Y.)

In common: Alzheimer's / dementia, structural MRI / diffusion, 5 references

[2] doi:10.3389/fpsyt.2026.1848053

Neuroanatomical substrates of perivascular space index: a morphometric and tractography study.

Journal: Frontiers in psychiatry

In common: structural MRI / diffusion, 5 references

[3] doi:10.1186/s12916-026-04948-z [code]

Putative glymphatic dysfunction links extracellular fluid dysregulation to white matter degeneration and clinical impairment in amyotrophic lateral sclerosis.

Journal: BMC medicine

In common: structural MRI / diffusion, clinical / translational, other condition, 4 references

[4] doi:10.1016/j.isci.2026.116581

Peripheral inflammation impairs glymphatic function, contributing to neurodegeneration in Alzheimer's disease.

Journal: iScience

In common: Alzheimer's / dementia, structural MRI / diffusion, 4 references

[5] doi:10.1093/braincomms/fcag235 [code]

Association between glymphatic dysfunction and glucose hypometabolism in chronic disorders of consciousness: a multimodal PET/MRI study.

Journal: Brain communications

In common: structural MRI / diffusion, other condition, 3 references

[6] doi:10.1038/s42003-026-10388-5 [code]

Hierarchical organization of tau topography across the Alzheimer's disease continuum integrates amyloid, connectome, and intrinsic molecular vulnerability.

Journal: Communications biology

In common: Alzheimer's / dementia, other condition, 3 references

[7] doi:10.3389/fneur.2026.1879894

Perivascular diffusion and white matter free water improve identification of cognitive impairment in cerebral small vessel disease.

Journal: Frontiers in neurology

In common: Alzheimer's / dementia, structural MRI / diffusion, clinical / translational, 2 references

[8] doi:10.1002/cns.71043

Multimodal Neuroimaging-Based Machine Learning Models Leveraging Cerebral Morphometry and Glymphatic Parameters Predict Short-Term Post-Programming STN-DBS Motor Response in Parkinson's Disease.

Journal: CNS neuroscience & therapeutics

In common: structural MRI / diffusion, clinical / translational, 2 references

[9] doi:10.1186/s12888-026-08304-6

Transcranial direct current stimulation improves reduced global BOLD-CSF coupling in patients with insomnia disorder and comorbid anxiety: a resting-state functional MRI study.

Journal: BMC psychiatry

In common: clinical / translational, other condition, 2 references

[10] doi:10.1002/alz.71745 [code]

Regional astrocyte dysregulation and altered glymphatic-related markers in Alzheimer's disease frontal cortex.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

In common: Alzheimer's / dementia, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.